Director: Patricia Keegan, M.D.
Deputy Director: Joseph Gootenberg, M.D.
Deputy Director of Safety: Jeffrey Summers, M.D.
SRPM: Karen Hennessy
Chief, Project Management Staff: Karen Jones
Chief, Project Management Staff: Monica Hughes
Secretary: Fustina (Tina) Lambert
The Division of Oncology Products 2 (DOP2) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs) and Biologic Licensing Applications (BLAs) for the following therapeutic areas:
- Gastrointestinal Cancers
- Lung/Head & Neck Cancers
- Neuro-oncology/Rare cancers/Pediatric Solid Tumor
Food and Drug Administration
Center for Drug Evaluation and Research
Division of Oncology Products 2 (DOP2)
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-2320
Fax: (301) 796-9849